6.46
6.46 (0.22%)
As of Feb 16, 2022
Gx Acquisition Corp. [CELU]
Source:
Company Overview
Celularity Inc is a clinical-stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. We are developing a pipeline of off-the-shelf placental-derived allogeneic cell therapy product candidates including T cells engineered with a chimeric antigen receptor, or CAR, natural killer, or NK, cells, mesenchymal-like adherent stromal cells, or MLASCs, and exosomes.
Country | United States |
Headquarters | florham park, new jersey |
Phone Number | (908) 768-2170 |
Industry | finance |
CEO | Robert J. Hariri |
Website | celularity.com |